** Shares in Corbion CORB.AS are up 5% after the Dutch
biochemicals group confirmed its FY24 outlook on the back of its
Q1 results
** KBC Securities says the Q1 core adj. EBITDA came slightly
better than expected at +0.7% organically vs -2% expected
** "Although the recent track record has been more volatile
than expected, the strategic choices made recently (sticking to
PLA, a disciplined investment approach on ao Algae, a much
increased FCF focus) make sense in our opinion" - KBC
** Up to the previous session's close, shares were down
3.9% YTD
(Reporting by Marianna Ciabach-Malinowska)
((Marianna.ciabach@tr.com))